John B. Sanfilippo & Son(JBSS) - 2026 Q2 - Quarterly Results

Financial Performance - Net sales for Q2 fiscal 2026 increased by $13.7 million, or 4.6%, to $314.8 million, driven by a 15.8% increase in the weighted average selling price per pound [3]. - Diluted earnings per share (EPS) rose by 31.9% to $1.53 per share, reflecting strong top-line growth [4]. - Gross profit increased by $6.9 million to $59.2 million, with gross profit margin improving to 18.8% of net sales from 17.4% in the prior year [8]. - Sales volume decreased by 9.3 million pounds, or 9.7%, to 87.0 million pounds, primarily due to declines in private brand sales and contract manufacturing [4]. Inventory and Assets - The value of total inventories increased by $29.6 million, or 14.4%, driven by higher commodity acquisition costs across major nut types [10]. - Total assets increased to $617.729 million, up from $597.603 million in the previous period, representing a growth of 1.9% [20]. - Cash reserves rose significantly to $2.4 billion from $585 million, indicating a strong liquidity position [20]. - Accounts receivable decreased slightly to $79.823 million from $76.656 million, reflecting a stable collection process [20]. - Inventories decreased to $235.427 million from $254.600 million, suggesting improved inventory management [20]. Liabilities and Equity - Current liabilities decreased to $148.406 million from $156.046 million, a reduction of approximately 4.1% [20]. - Long-term debt increased to $28.839 million from $14.564 million, indicating potential leverage for future growth [20]. - Retained earnings grew to $228.981 million from $221.495 million, showing a positive trend in profitability [20]. - Total stockholders' equity increased to $370.124 million from $360.697 million, reflecting a healthy equity position [20]. - The company reported a decrease in accounts payable to $79.897 million from $60.479 million, indicating better cash flow management [20]. - The company maintained a consistent dividend policy with dividends payable recorded at $11.704 million [20]. Strategic Initiatives - The company distributed a special dividend of $1.00 per share, reflecting a strong financial position and disciplined capital allocation strategy [12]. - The company is expanding its product pipeline with new innovations to align with emerging health and wellness trends [2]. - The recent reduction in trade tariffs on imported nuts is expected to help lower selling prices over time and support future demand [2]. - The company anticipates continued growth opportunities despite headwinds from shifting consumer behavior and elevated retail prices [2]. Operating Expenses - Operating expenses increased slightly by $0.3 million, but as a percentage of net sales, they declined to 10.5% from 10.9% in the prior year [9].